新綸新材(002341.SZ):致力於成為新材料領域數一數二的服務商
格隆匯5月24日丨有投資者向新綸新材(002341.SZ)提問:請問公司主營業務是什麼?發展前景如何?
新綸新材回覆:公司專業從事先進功能性高分子材料的研發、生產、銷售以及新材料的精密製造,輔以淨化工程業務和個人防護用品的生產銷售。公司以高端精密塗布技術為核心,以“固根基、揚優勢、補短板、強弱項”的國家產業政策為導向,以破解新材料領域“卡脖子”技術難題為目標,在新材料行業的多個細分領域實現技術突破,打破了國際巨頭數十年以來的產業壟斷和技術封鎖。公司致力於成為新材料領域數一數二的服務商,助力國家在高分子新材料產業實現全面化國產替代和技術升級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.